Global
簡體中文 English

新聞中心

新聞中心

時間:2021-06-28


The Center for Pharma Crystallization (CfPC) at J-Star Research, Inc., a subsidiary of Porton Pharma Solutions, is pleased to announce the program of 2nd annual Pharmaceutical Crystallization Summit, to be held on October 14 and 15, 2021, jointly with our partners XtalPi, BlazeMetrics, and Technobis.   博騰股份子公司J-Star Research的藥物結晶中心(CfPC)近日宣布,將于2021年10月14日至15日聯合晶泰科技、BlazeMetrics和Technobis舉辦第二屆全球藥物結晶高峰論壇。

 

The 2-day event includes 4 sessions, with 12 keynote presentations by leading industrial and academic experts, and 3 topical panel discussions moderated by SMEs from the pharma industry. See topical and speaker details at.   這兩天的峰會將采用線上與線下相結合的方式,共有12個主題報告和3個專題討論,分別由制藥行業專家來主持。如需詳情,請跳轉以下地址:

www.pharmaceuticalcrystallizationsummit.com


Areas of opportunity identified by Enabling Technologies Consortium (ETC)  賦能技術聯盟(ETC)確認的潛在發展領域

Crystal structure prediction 晶體結構預測

Crystal shape prediction 晶體形貌預測

Solubility assessment 溶解度評估

Purification 純化

Analytical technologies 分析技術


Areas of potential innovation identified by National Academies of Sciences, Engineering, and Medicine (NASEM)

美國國家科學工程醫藥學院(NASEM)確認的潛在創新領域

Co-processed APIs 協同加工API

Process intensification 過程強化

Additive manufacturing 制劑輔料生產

Advanced process control & automation 先進過程控制與自動化

Modular systems 模塊化系統



議程安排

(以下時間均為北京時間


 第一天  

Thursday, October 15, 2021  

 2021年10月15日星期五

Session 1: Smarter Solid Form & Pre-formulation Studies  

論壇1:更智能的固態和處方前制劑研究

Moderator: Dr. Shanming Kuang 

主持人:匡善明博士


Dr. Shanming Kuang

Head of Center for Pharma Crystallizationat Shanghai Branch, Porton Pharma Solutions Senior Director of Solid Form Studies, Center for Pharma Crystallization, J-Star Research Inc.

博騰上海藥物結晶中心主任/

J-STAR藥物結晶中心固態研發高級總監



20:15 - 21:05

Dr. Alfred Lee | Principal Scientist

Merck Research Laboratories

Topic 議題

Development of a Green and Sustainable Manufacturing Process for Gefapixant Citrate (MK-7264): A Solid-State Chemistry Perspective 

從固態化學角度探討綠色可持續的Gefapixant枸櫞酸(MK-7264)生產工藝的開發


21:05 - 21:55

Dr. Ann Newman

Solid-State and Pharmaceutical Consultant

Seventh Street Development Group

Topic 議題

What Solid Form Should I Choose?

如何選擇固體形態?


22:15 – 23:05

Dr. Shawn Yin | Research Fellow

Bristol-Myers Squibb

Topic 議題

Understanding and Controlling the API Form/Powder Property Risks in Drug Substance and Product Processes

理解并控制原料藥和成品藥工藝過程中關于晶型/粉末特性的風險


23:05 - 23:55

Dr. Jessica Bruhn | Principal Scientist

NanoImaging Services


Chandler Greenwell | Applications Scientist

XtalPi Inc.


Dr. Harsh Shah 

Senior Scientist

J-Star Research


Topic 議題

Absolute Structure Determination of API Molecules by MicroED Analysis of Co-Crystals Formed Based on COSMO-RS Prediction

基于COSMO-RS預測制備共晶并用MicroED分析共晶確定原料藥分子的絕對結構



Thursday, October 15, 2021  

 2021年10月15日星期五

Session 2: Particle Engineering & DS-DP Co-Processing   

論壇2:粒子工程和原料藥-成品藥協同加工

Moderator: Dr. San Kiang

主持人:江山博士

Dr. San Kiang

Chief Technology Officer     

Porton Pharmatech/J-Star Research

重慶博騰藥業有限公司/J-STAR

首席技術官



01:05 - 01:55

Dr. Christopher Burcham

Senior Engineering Research Advisor

Eli Lilly and Company

Topic 議題

Examples of Particle Engineering to Improve Patient Outcomes and Product Manufacturing

通過粒子工程幫助患者改善產品生產的幾個案例

01:55 - 02:45

Prof. Junbo Gong

School of Chemical Engineering and Technology    

Tianjin University

Topic 議題

Crystal habit modifications and spherical crystallization design in solution

溶液中調控晶習和球型結晶設計

03:05 - 03:55

Prof. Changquan Calvin Sun

Professor, Director of Graduate Studies, and Associate Department Head, Department of Pharmaceutics

University of Minnesota

Topic 議題

Challenges and Opportunities in Optimizing Mechanical Properties of Drugs by Incorporating Excipients

加入輔料優化藥物力學性能面臨的挑戰和機遇

03:55 - 04:45

Dr. Jian Wang

SVP, Center for Pharma Crystallization, Porton/J-Star

Topic 議題

Bridging the Gap between Drug Substance and Drug Product Productions via Co-Processing

通過原料藥與成品藥的協同加工來克服藥物生產中的瓶頸問題


第二天

Friday, October 16, 2021  

2021年10月16日,星期六

Session 3: Physical Property Based Crystallization Process Development 

論壇3:基于物理屬性的結晶工藝研發

Moderator: Dr. Yuriy Abramov

主持人:Yuriy Abramov博士

Dr. Yuriy A.Abramov    

VP of Scientific Affairs XtalPi Inc.

Yuriy A.Abramov博士 

晶泰科技/科學事務副總裁



20:15 - 21:05

Prof. Kevin J Roberts

Brotherton Professor of Chemical Engineering

University of Leeds

Topic 議題

The Importance of Understanding and Characterising the Physical & Chemical Properties of APIs in the Digital Design of Drug Products

理解并表征原料藥理化性質對于成品藥數字化設計的重要性

21:05 - 21:55

Prof. Allan Myerson

Professor of the Practice

Massachusetts Institute of Technology

Topic 議題

Continuous Crystallization and Purification:The Role of Impurity Incorporation Mechanism in Non-Equilibrium Processes

連續結晶與純化:含雜機理對非平衡工藝過程的重要性

22:15 – 23:05

Dr. Samir Kulkarni

Principal Scientist

Pfizer

Topic議題

Co-Crystals Platform to Improve Physical Properties of Early Intermediates during API Manufacturing Process

改善原料藥制備工藝中前步中間體物理性質的共晶平臺


23:05 - 23:55

Prof. Kenneth Morris

University Professor    

Long Island University

Director of the Lachman Institute for Pharmaceutical Analysis

Topic 議題

Correlation of Solubility with the Metastable Limit

溶解度與介穩極限的關聯模擬



Friday, October 16, 2021  

2021年10月16日,星期六

Session 4: Topical Panel Discussions  

論壇4:專題討論

Moderator: Dr. Alfred Lee  

主持人:Alfred Lee 博士

Dr. Alfred Lee

Principal Scientist

Merck Research Laboratories

Alfred Lee 博士 默克研究實驗室Principal Scientist



01:10 – 01:45

Dr. Alfred Lee

Principal Scientist

Merck Research Laboratories

Topic 議題

Potentials and Technologies to Increase Success Rate of Polymorph Screening

提高晶型篩選成功率的潛力和技術


01:45 – 02:20

Kevin Girard

Associate Research Fellow

Pfizer

Topic 議題 

Overcoming Industrial Challenges in Implementation of Crystallization Technologies

克服實施結晶技術面臨的工業問題


02:20 – 02:55

Dr. Christopher Burcham

Senior Engineering Research Advisor

Eli Lilly and Company

Topic 議題

Realizing   Regulatory Challenges in Applying Crystallization Technologies

克服應用結晶技術面臨的監管問題

02:55 – 03:00

Closing Remarks by Chairman, Dr. San Kiang, J-Star Research/Porton 

大會主席致閉幕詞

San Kiang 博士

博騰/J-STAR


“Serving the patients with the right DP (drug product) in the fastest way possible requires scientists on the API (active pharmaceutical ingredient) side, and DP side to work hand in hand, not in isolation. The speakers at this conference will demonstrate how this kind of collaboration can lead to experimental and theoretical tools to better understand the fundamentals of APIs, their interaction with excipients, API crystallization and formulation processes.” stated by Dr. San Kiang, CTO of Porton, Chairman of the Pharmaceutical Crystallization Summit.


“為了盡快給患者研發出好的成品藥,原料藥科學家和成品藥科學家應打破孤立攜手合作。本次峰會的演講嘉賓們會有力地說明,如何通過攜手合作,融合實踐經驗和理論技術的邊際,來幫助理解原料藥的基本原理、原料藥與輔料的相互作用以及原料藥結晶和配方工藝。” 

——本屆藥物結晶高峰論壇主席、博騰藥業CTO江山博士。


“I’m really excited about this year’s Summit. The superb program that is in place will offer in-depth scientific and technical discussions on crystallization technologies, geared towards overcoming hurdles in new drug development programs,” said by Dr. Jian Wang, SVP, CfPC at J-Star Research. “I look forward to meeting both old and new friends in the pharma crystallization field in October.”


“對于今年的峰會,我真的很興奮。已經準備好的峰會內容將給參會者們提供關于結晶技術的深入科學技術性討論,旨在攻克新藥開發中的難題。我十分期待10月份與藥物結晶領域的新老朋友相會。”

——博騰/JSTAR 高級副總裁王建博士。


Please contact cfpc@jstar-research.com for any question you may have. We look forward to seeing you at the Summit.

如有疑問,請聯系 cfpc@jstar-research.com。

我們期待在峰會相見。


Warmly welcome our friends to follow us on this Summit in the coming months.

熱烈歡迎大家持續關注。


SHARE :

返回

上一頁 下一頁

法律聲明 關于博騰 投資者

重慶市北碚區水土高新園區方正大道

Copyright ? 2020 Porton Group. DIGITAL BY VTHINK

渝ICP備11005917號-1

渝公網安備 50010902000907號

亚洲一区无码精品色,久久亚洲AV无码专区首页,亚洲中文无码亚洲人成手机版